BioDiem Ltd - Financial and Strategic SWOT Analysis Review

Document Sample
BioDiem Ltd - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					                     BioDiem Ltd - Financial and Strategic SWOT Analysis Review
        Reference Code: GDPH61751FSA                                                                                                                          Publication Date: JAN 2014

       Table of Contents
       Table of Contents ............................................................................................................................................................................... 1
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 5
       BioDiem Ltd - Key Facts ..................................................................................................................................................................... 5
       BioDiem Ltd - Key Employees ............................................................................................................................................................ 6
       BioDiem Ltd - Key Employee Biographies .......................................................................................................................................... 7
       BioDiem Ltd - Key Operational Employees ........................................................................................................................................ 8
       BioDiem Ltd - Major Products and Services ....................................................................................................................................... 9
       BioDiem Ltd - Pharmaceutical Pipeline Products Data..................................................................................................................... 10
          BioDiem Ltd, Pipeline Products by Therapy Area ......................................................................................................................... 10
          BioDiem Ltd, Pipeline Products by Development Phase............................................................................................................... 11
       BioDiem Ltd - History ....................................................................................................................................................................... 13
       BioDiem Ltd - Locations And Subsidiaries........................................................................................................................................ 15
          Head Office ................................................................................................................................................................................... 15
          Other Locations & Subsidiaries ..................................................................................................................................................... 15
       Section 2 – Company Analysis ......................................................................................................................................................... 16
       BioDiem Ltd - Business Description ................................................................................................................................................. 16
       BioDiem Ltd - SWOT Analysis.......................................................................................................................................................... 17
          SWOT Analysis - Overview........................................................................................................................................................... 17
          BioDiem Ltd - Strengths ................................................................................................................................................................ 17
             Strength - LAIV Technology ...................................................................................................................................................... 17
             Strength - Strong Research and Development Capabilities ...................................................................................................... 17
             Strength - Global Partnering/Commercialization Network ......................................................................................................... 17
          BioDiem Ltd - Weaknesses........................................................................................................................................................... 17
             Weakness - Negative Operating Margin.................................................................................................................................... 17
             Weakness - Limited Liquidity Position ....................................................................................................................................... 17
          BioDiem Ltd - Opportunities .......................................................................................................................................................... 18
             Opportunity - Product Pipeline .................................................................................................................................................. 18
             Opportunity - Potential Market................................................................................................................................................... 18
             Opportunity - Changing Demographics ..................................................................................................................................... 18
          BioDiem Ltd - Threats ................................................................................................................................................................... 18
             Threat - Competition.................................................................................................................................................................. 18
             Threat - Uncertain R&D Outcomes ........................................................................................................................................... 18
       BioDiem Ltd - Key Competitors ........................................................................................................................................................ 19
       Section 3 – Company Financial Ratios ............................................................................................................................................. 20
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 20
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 20
       Performance Chart ........................................................................................................................................................................... 22
       Financial Performance...................................................................................................................................................................... 22
       Financial Ratios - Interim Ratios....................................................................................................................................................... 23
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 24
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 25


BioDiem Ltd - Financial and Strategic SWOT Analysis Review                                                                                                     Reference Code: GDPH61751FSA
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
          BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 ........................................................................ 25
          BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014 ........................................................................ 26
       BioDiem Ltd, Recent Deals Summary .............................................................................................................................................. 27
       Section 5 – Company’s Recent Developments ................................................................................................................................ 28
          BioDiem Ltd, Recent Developments ............................................................................................................................................. 28
             Dec 05, 2013: BioDiem Announces Publication of Research in Journal of Virology ................................................................. 28
             Oct 28, 2013: BioDiem Announces Confirmation of Delisting from ASX ................................................................................... 28
             Oct 25, 2013: BioDiem Announces Change of Principal Place of Business and Registered Office .......................................... 28
             Oct 24, 2013: China presentation of BioDiem’s liver treatment technology ............................................................................... 29
             Aug 30, 2013: BioDiem Reports Proposed Delisting from ASX................................................................................................. 29
             Jul 22, 2013: Proof of Principle shown in liver disease vaccine program
				
DOCUMENT INFO
Description: BioDiem Ltd - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights BioDiem Ltd. (BioDiem) is an Australian biotechnology company based in Melbourne, with a focus on developing an
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.